Literature DB >> 2582722

Effect of ligustrazine on pulmonary vascular changes induced by chronic hypoxia in rats.

Y N Cai1, G R Barer.   

Abstract

1. Acute and chronic effects on the pulmonary circulation of ligustrazine, a chemically identified and synthesized principle of a Chinese herb, were studied in rats. It dilated lung vessels and reversed hypoxic pulmonary vasoconstriction. 2. In rats kept 2 weeks in 10% O2 in a normobaric chamber and simultaneously treated with ligustrazine, right ventricular hypertrophy and muscularization of pulmonary arterioles were attenuated compared with saline-treated rats. Pulmonary artery pressure, measured in isolated lungs perfused at a constant flow rate, was also less in ligustrazine-treated rats. 3. In isolated blood-perfused lungs of chronically hypoxic and control rats, the relation between pressure and flow was measured during normoxia (ventilation with air plus 5% CO2), hypoxia (2% O2 plus 5% CO2) and after ligustrazine during continued hypoxia. Alveolar pressure was always greater than left atrial pressure; thus flow was determined by the pulmonary artery minus alveolar pressure difference. 4. Pressure/flow lines were measured during normoxia in four groups of rats: (1) control, saline-treated; (2) control, ligustrazine-treated; (3) chronically hypoxic, saline-treated; (4) chronically hypoxic, ligustrazine-treated. Both chronically hypoxic groups had steeper lines (higher resistance) than the control groups, which were similar in all respects. However, in chronically hypoxic rats, the extrapolated intercept of the line on the pressure axis, probably attributable to small newly muscularized arterioles in a state of tone, was much increased in the saline-treated group but did not differ from controls in the ligustrazine-treated group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2582722     DOI: 10.1042/cs0770515

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  6 in total

1.  Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart.

Authors:  J Feng; R Liu; G Wu; S Tang
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

2.  Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous L-arginine-dependent mechanism.

Authors:  W Peng; D Hucks; R M Priest; Y M Kan; J P Ward
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Inhibition of acid sensing ion channel by ligustrazine on angina model in rat.

Authors:  Zhi-Gang Zhang; Xiao-Lan Zhang; Xian-Yue Wang; Zhu-Rong Luo; Jing-Chun Song
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

4.  Effect of antenatal tetramethylpyrazine on lung development and YAP expression in rat model of experimental congenital diaphragmatic hernia.

Authors:  Junzuo Liao; Wenying Liu; Libin Zhang; Qin Li; Fang Hou; Pingjin Zou
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

5.  Pulmonary vascular disease in a rabbit at high altitude.

Authors:  D Heath; D Williams; J Rios-Dalenz; J Gosney
Journal:  Int J Biometeorol       Date:  1990-05       Impact factor: 3.787

6.  Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension.

Authors:  Yuqin Chen; Wenju Lu; Kai Yang; Xin Duan; Mengxi Li; Xiuqing Chen; Jie Zhang; Meidan Kuang; Shiyun Liu; Xiongting Wu; Guofa Zou; Chunli Liu; Cheng Hong; Wenjun He; Jing Liao; Chi Hou; Zhe Zhang; Qiuyu Zheng; Jiyuan Chen; Nuofu Zhang; Haiyang Tang; Rebecca R Vanderpool; Ankit A Desai; Franz Rischard; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan; Nanshan Zhong; Jian Wang
Journal:  Br J Pharmacol       Date:  2020-04-27       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.